Contribution: Industrial Research Assistance Program – Contributions to Firms
Kisoji Biotechnologie Inc.
$550,000.00
Kisoseek: A biotechnology platform for SdAb selection for cancer treatment
FY 2022-23 · 2022-07-01
Summary
Through the development and application of cutting-edge machine learning algorithms, the firm seek to build an end-to-end AI-enabled platform, KisoSeek, that will use machine learning to search and identify therapeutic cancer antibodies.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Montreal|Montreal, Quebec, Canada
Recipient Type
For-profit organization
Business Number
858257454
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2022-07-01 | 2022-23 | $500,000.00 |
| 3 | 2022-07-01 | 2022-23 | $550,000.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 32 days. The total amended value is 50,000 dollars.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 32 jours. La valeur totale des modifications est de 50 000 dollars.
Agreement End Date
2023-10-31
Agreement Number
993405
Agreement Start Date
2022-07-01
Agreement Title
Kisoseek: A biotechnology platform for SdAb selection for cancer treatment
Agreement Title (French)
Kisoseek : Une plateforme biotechnologique pour la sélection d'anticorps à domaine unique pour le traitement du cancer
Agreement Type
Contribution
Agreement Value
$550,000.00
Amendment Date
2023-09-28
Amendment Number
3
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Through the development and application of cutting-edge machine learning algorithms, the firm seek to build an end-to-end AI-enabled platform, KisoSeek, that will use machine learning to search and identify therapeutic cancer antibodies.
Description (French)
Grâce au développement et à l'application d'algorithmes d'apprentissage automatique de pointe, la société cherche à construire une plateforme d'IA de bout en bout, KisoSeek, qui utilisera l'apprentissage automatique pour rechercher et identifier des anticorps thérapeutiques contre le cancer.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Ville-Marie--Le Sud-Ouest--Île-des-Soeurs
Federal Riding (French)
Ville-Marie--Le Sud-Ouest--Île-des-Soeurs
Federal Riding Number
24077
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
858257454
Recipient City
Montreal|Montreal
Recipient Country
CA
Recipient Legal Name
Kisoji Biotechnologie Inc.
Recipient Postal Code
H2X 2J1
Recipient Province or Territory
QC
Recipient Type
F
Reference Number
172-2022-2023-Q2-993405
